A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
for Severe Hypertriglyceridemia
29 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07269210·Phase 2·Recruiting·Listed Dec 2025
Axsendo Clinical Research - Peak Heart & Vascular - Phoenix
Clinical research site in Phoenix, Arizona · Peak Heart & Vascular, 1277 E Missouri Ave #208, Phoenix, AZ 85014 · (602) 698-7325 · Website
Part of Axsendo Clinical Research
As of July 2026, 2 paid clinical trials are recruiting at Axsendo Clinical Research - Peak Heart & Vascular - Phoenix in Phoenix, Arizona. Active studies at this site cover conditions such as Severe Hypertriglyceridemia, Elevated Lp(a) and Atherosclerotic Cardiovascular Disease (ASCVD). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Axsendo Clinical Research - Peak Heart & Vascular - Phoenix (2)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
127 locations incl. Gilbert
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
More research sites in Phoenix
- Phoenix Children's Hospital (65 trials)
- Cancer Center at Saint Joseph's (39 trials)
- Mayo Clinic Hospital in Arizona (35 trials)
- Mayo Clinic (34 trials)
- Phoenix Childrens Hospital (33 trials)
- Mayo Clinic Arizona (32 trials)
- Barrow Neurological Institute (31 trials)
- Mayo Clinic Hospital (20 trials)
- St. Joseph's Hospital and Medical Center (17 trials)
- Arizona State University (15 trials)
Explore more
Paid clinical trials in Phoenix, AZ · Arizona clinical trials